{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:40:26Z","timestamp":1648885226580},"reference-count":36,"publisher":"Oxford University Press (OUP)","issue":"Supplement_1","license":[{"start":{"date-parts":[[2019,2,15]],"date-time":"2019-02-15T00:00:00Z","timestamp":1550188800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,2,15]]},"DOI":"10.1093\/cid\/ciy928","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T20:12:03Z","timestamp":1543954323000},"page":"S42-S45","source":"Crossref","is-referenced-by-count":3,"title":["A Global Agenda for Typhoid Control\u2014A Perspective from the Bill &amp; Melinda Gates Foundation"],"prefix":"10.1093","volume":"68","author":[{"given":"Megan E","family":"Carey","sequence":"first","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoey I","family":"Diaz","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita K M","family":"Zaidi","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Duncan","family":"Steele","sequence":"additional","affiliation":[{"name":"Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,2,15]]},"reference":[{"key":"key\n\t\t\t\t2019021500100030200_CIT0001","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1093\/cid\/civ976","article-title":"Challenges and opportunities for typhoid fever control: a call for coordinated action","volume":"62 Suppl 1","author":"Steele","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0002","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","author":"GBD 2016 Causes of Death Collaborators","year":"2017","journal-title":"The Lancet"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0003","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0004","doi-asserted-by":"crossref","first-page":"e0005376","DOI":"10.1371\/journal.pntd.0005376","article-title":"The burden of typhoid fever in low- and middle-income countries: a meta-regression approach","volume":"11","author":"Antill\u00f3n","year":"2017","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0005","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/cid\/civ295","article-title":"Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study","volume":"61","author":"Mohan","year":"2015","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0006","first-page":"153","article-title":"Typhoid vaccines: WHO position paper\u2013March 2018","volume":"13","author":"World Health Organization","year":"2018","journal-title":"Wkly Epidemiol Rec"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0007","author":"Gavi"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0008","doi-asserted-by":"crossref","first-page":"e00105","DOI":"10.1128\/mBio.00105-18","article-title":"Emergence of an extensively drug-resistant Salmonella enterica serovar Typhi clone harboring a promiscuous plasmid encoding resistance to fluoroquinolones and third-generation cephalosporins","volume":"9","author":"Klemm","year":"2018","journal-title":"mBio"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0009","doi-asserted-by":"crossref","first-page":"e00482","DOI":"10.1128\/mBio.00482-18","article-title":"The gathering storm: is untreatable typhoid fever on the way","volume":"9","author":"Levine","year":"2018","journal-title":"mBio"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0010","doi-asserted-by":"crossref","first-page":"e310","DOI":"10.1016\/S2214-109X(17)30022-0","article-title":"Incidence of invasive salmonella disease in sub-Saharan Africa: a multicentre population-based surveillance study","volume":"5","author":"Marks","year":"2017","journal-title":"Lancet Glob Health"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0011","doi-asserted-by":"crossref","first-page":"70","DOI":"10.4103\/ijmm.IJMM_17_412","article-title":"Changing trends of culture-positive typhoid fever and antimicrobial susceptibility in a tertiary care North Indian Hospital over the last decade","volume":"36","author":"Sharma","year":"2018","journal-title":"Indian J Med Microbiol"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0012","doi-asserted-by":"crossref","first-page":"e0006408","DOI":"10.1371\/journal.pntd.0006408","article-title":"Laboratory and molecular surveillance of paediatric typhoidal salmonella in Nepal: antimicrobial resistance and implications for vaccine policy","volume":"12","author":"Britto","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0013","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/civ675","article-title":"What have we learned from the Typhoid Fever Surveillance in Africa Program","volume":"62","author":"Baker","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0014","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.2471\/BLT.06.039818","article-title":"A study of typhoid fever in five Asian countries: disease burden and implications for controls","volume":"86","author":"Ochiai","year":"2008","journal-title":"Bull World Health Organ"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0016","doi-asserted-by":"crossref","article-title":"Phase I of the Surveillance for Enteric Fever in Asia Project (SEAP): an overview and lessons learned","author":"Barkume","DOI":"10.1093\/infdis\/jiy522"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0017","article-title":"High rates of enteric fever diagnosis and lower burden of culture-confirmed disease in peri-urban and rural Nepal","author":"Andrews","year":"2017","journal-title":"J Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0018","doi-asserted-by":"crossref","first-page":"e0004616","DOI":"10.1371\/journal.pntd.0004616","article-title":"The burden of typhoid and paratyphoid in India: systematic review and meta-analysis","volume":"10","author":"John","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0019","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1186\/s12889-018-5498-2","article-title":"Estimating the incidence of enteric fever in children in India: a multi-site, active fever surveillance of pediatric cohorts","volume":"18","author":"John","year":"2018","journal-title":"BMC Public Health"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0020","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1093\/cid\/cix185","article-title":"Treatment response in enteric fever in an era of increasing antimicrobial resistance: an individual patient data analysis of 2092 participants enrolled into 4 randomized, controlled trials in Nepal","volume":"64","author":"Thomson","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0021","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1002\/nmi2.46","article-title":"Multi-drug resistance and reduced susceptibility to ciprofloxacin among Salmonella enterica serovar Typhi isolates from the Middle East and Central Asia","volume":"2","author":"Rahman","year":"2014","journal-title":"New Microbes New Infect"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0022","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1128\/JCM.02026-14","article-title":"Genomic signature of multidrug-resistant Salmonella enterica serovar Typhi isolates related to a massive outbreak in Zambia between 2010 and 2012","volume":"53","author":"Hendricksen","year":"2015","journal-title":"J Clin Microbiol"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0023","doi-asserted-by":"crossref","first-page":"e0003748","DOI":"10.1371\/journal.pntd.0003748","article-title":"Rapid emergence of multidrug resistant, H58-lineage Salmonella Typhi in Blantyre, Malawi","volume":"9","author":"Feasey","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0024","doi-asserted-by":"crossref","first-page":"e0004781","DOI":"10.1371\/journal.pntd.0004781","article-title":"Molecular surveillance identifies multiple transmissions of typhoid in West Africa","volume":"10","author":"International Typhoid Consortium","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0025","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/ng.3281","article-title":"Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events","volume":"47","author":"Wong","year":"2015","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0026","doi-asserted-by":"crossref","first-page":"e01229","DOI":"10.7554\/eLife.01229","article-title":"Fitness benefits in fluoroquinolone-resistant Salmonella Typhi in the absence of antimicrobial pressure","volume":"2","author":"Baker","year":"2013","journal-title":"Elife"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0027","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1586\/eri.11.47","article-title":"The utility of diagnostic tests for enteric fever in endemic locations","volume":"9","author":"Parry","year":"2011","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0028","first-page":"421","article-title":"The laboratory diagnosis of enteric fever","volume":"2","author":"Wain","year":"2008","journal-title":"J Infect Dev Ctries"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0029","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella Typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0030","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1016\/S0140-6736(17)32149-9","article-title":"Efficacy and immunogenicity of a Vi-tetanus toxoid conjugate vaccine in the prevention of typhoid fever using a controlled human infection model of Salmonella Typhi: a randomised controlled, phase 2b trial","volume":"390","author":"Jin","year":"2017","journal-title":"Lancet"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0031","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/cid\/cix1145","article-title":"Seroefficacy of Vi polysaccharide-tetanus toxoid typhoid conjugate vaccine (Typbar TCV)","volume":"67","author":"Voysey","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0032","doi-asserted-by":"crossref","first-page":"5081","DOI":"10.1016\/j.vaccine.2017.08.001","article-title":"The Typhoid Vaccine Acceleration Consortium (TyVAC): vaccine effectiveness study designs: accelerating the introduction of typhoid conjugate vaccines and reducing the global burden of enteric fever. Report from a meeting held on 26-27 October 2016, Oxford, UK","volume":"35","author":"Meiring","year":"2017","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0033","unstructured":"Development \u2013 IVI Homepage. http:\/\/www.ivi.int\/?page_id=12360"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0034","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1016\/j.vaccine.2018.05.038","article-title":"Safety and immunogenicity of a Vi-DT typhoid conjugate vaccine: phase I trial in healthy Filipino adults and children","volume":"36","author":"Capeding","year":"2018","journal-title":"Vaccine"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0035"},{"key":"key\n\t\t\t\t2019021500100030200_CIT0036"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/Supplement_1\/S42\/27783420\/ciy928.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,6]],"date-time":"2019-11-06T18:54:01Z","timestamp":1573066441000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/Supplement_1\/S42\/5320153"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,15]]},"references-count":36,"journal-issue":{"issue":"Supplement_1","published-online":{"date-parts":[[2019,2,15]]},"published-print":{"date-parts":[[2019,2,15]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy928","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,15]]},"published":{"date-parts":[[2019,2,15]]}}}